BioSpace News Archive

Robot sits at big arrow, symbolising a growth of AI technology. 3D rendering

Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.

April 1, 2026

·

6 min read

·

Tristan Manalac

Decorative border of fly different flavor ice cream cones in waffle - white, pink, brown with chocolate sauce on pink.

Mergers & acquisitions

Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B

Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.

April 1, 2026

·

1 min read

Pills, capsules and tablets that shape the map of the world, as a symbol for global medicine issues. Vector illustration.

Drug pricing

Trump’s MFN Pricing Expected To Delay More European Drug Launches

Following Insmed’s decision to hold off on launching a newly approved lung disease drug in Europe, experts anticipate more companies will do the same as they seek to avoid price erosion in the U.S. Will Chinese biotechs fill the void?

April 1, 2026

·

3 min read

·

Nick Paul Taylor

3D rendering of a Syringe Shield and multiple instances of the international radioactive hazard symbol or the trefoil icon.

Insights

The Brave New World of Radiotherapeutics

Convergent Therapeutics’ Dr. Philip Kantoff and Plus Therapeutics’ Dr. Marc Hedrick discuss how unmet medical needs, maturing isotope supply chains and innovative delivery are positioning targeted radiation as oncology’s next big platform.

April 1, 2026

·

4 min read

·

Jennifer C. Smith-Parker

Career Advice

3 Career Moves R&D Professionals Must Make in a Skills-Based, AI-Driven Economy

As AI reshapes deeply specialized scientific work, R&D professionals must learn to navigate the shift to a skills-centered market. The key is knowing which skills to develop and how to leverage AI as scientific modalities evolve, technologies advance and regulatory complexity increases.

April 1, 2026

·

5 min read

·

Kenneth Munie

Press Releases

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

April 1, 2026

·

4 min read

Press Releases

Axiom Medical Signal Summit 2026 Showcases the Power of Early Action and Complete Case Management